Retatrutide

Research Of Retatrutide Benefits：

1. Suppresses Appetite, Delays Gastric Emptying, and Stimulates Insulin

1）Mechanism of Action in Appetite Control：

In an animal study, researchers fasted male obese mice for 16 hours and treated them with long-acting glucagon receptor agonists, Retatrutide, galectin peptides, and other GLP-1 analogs for weight management. The study evaluated gastric emptying (GE) delay, body weight, and food intake.

2）Glucose-Dependent Gastric Emptying Delay:

Notably, Retatrutide delayed GE in a glucose-dependent manner. In particular, the group receiving 10 nmol/L Retatrutide showed the highest reduction in body weight and the largest decrease in food consumption.

3）Central Nervous System Effects:

Similarly to other GLP-1 receptor agonist, Retatrutide acts directly on the central nervous system, enhancing satiety and slowing gastric emptying. As a result, it supports effective obesity treatment.

4）Clinical Trial Weight Loss Results:

For example, a Phase 2 clinical trial reported significant weight loss in overweight and obese adults: 17.5% at 24 weeks and 24.4% at 48 weeks.

2. Treats Type 2 Diabetes

• A Phase 1b multiple ascending-dose study involved type 2 diabetes patients receiving weekly doses of Retatrutide or other glucose-lowering drugs, with a control group receiving no treatment.
• Remarkably, Retatrutide achieved 100% of the weight loss target, compared to only 2.1% in the control group. In contrast, no other diabetes drug reached 50% efficacy.
• These findings clearly demonstrate Retatrutide’s superior effectiveness in managing type 2 diabetes. However, the most common side effects were gastrointestinal.
• At the same time, in obese adults, Retatrutide treatment also led to significant weight loss over 48 weeks.

3. Promotes Energy Expenditure

• As a triple agonist, Retatrutide activates the glucagon receptor similarly to glucagon. Specifically, it directly stimulates thermogenesis and fat breakdown.
• It is important to note that glucagon receptors are present in the liver and adipose tissue. By activating these receptors, Retatrutide increases energy expenditure and heat production in the liver.
• Consequently, it boosts metabolic rate and promotes fat oxidation.

4. Reduces Inflammation and Treats Fatty Liver Disease

1）Anti-Inflammatory Benefits：

Retatrutide offers multi-faceted anti-inflammatory benefits. For instance, studies show it improves glucose tolerance, reduces body weight and fat mass, and enhances lipid profiles.

2）Reversal of Steatohepatitis in Mice：

Additionally, it reverses steatohepatitis in female mice, supporting resolution of fatty liver disease by reducing hepatic steatosis. In one study, mice that researchers fed a high-fat, high-sugar diet for 38 weeks received subcutaneous Retatrutide, and researchers fasted them for 4 hours.

Subsequently, histological analysis showed over 80% had definite steatohepatitis. Importantly, Retatrutide improved the condition dose-dependently, with some females showing complete reversal.

3）Histological Analysis Results：

In another human trial, researchers treated 98 participants with ≥10% liver fat content. After 48 weeks of Retatrutide treatment, liver fat decreased by 51.3% (1 mg), 59% (4 mg), and 86% (12 mg), compared to 4.6% in the control group.

Ultimately, all treated patients achieved normal liver fat levels.